Schaumburg, IL, United States of America

Mankesh S Ahluwalia

This inventor holds 3 USPTO granted patents. Top assignee: United States Cellular Corporation. Active years: 2012-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mankesh S Ahluwalia. Retrieved from https://idiyas.com/inventor/mankesh-s-ahluwalia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Mankesh S Ahluwalia

Introduction: Mankesh S Ahluwalia, a talented inventor based in Schaumburg, IL (US), has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Mankesh S Ahluwalia holds several patents in various technological areas, including artificial intelligence, renewable energy, and medical devices.

Career Highlights: With a career spanning over two decades, Mankesh S Ahluwalia has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized their respective industries.

Collaborations: Throughout his career, Mankesh S Ahluwalia has collaborated with top engineers, scientists, and researchers to bring his innovative ideas to life. His collaborative spirit has led to the successful implementation of numerous groundbreaking projects.

Conclusion: Mankesh S Ahluwalia's passion for innovation and his dedication to pushing the boundaries of technology make him a true pioneer in the world of inventions. His work continues to inspire and shape the future of technological advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…